PHI · 2025-26
Tyrese Maxey
- PTS/G
- 28.3
- REB/G
- 4.1
- AST/G
- 6.6
- TS%
- 58.8%
- RNP
- 464.0
- PRF
- 3089.0
Season RNP is higher than about ~98% of qualified players (same season as the leaderboard: 549 players with 5+ GP; rank 13). Population & rules →
Running Net Points are not opponent-adjusted. Use home/away and opponent labels as schedule context, not as adjustments to the stat.
Latest game — possession RNP
Sun · Apr 12 · vs MILHome · W 126–106
Game log
2025-26 · 70 games · through Sun · Apr 12
| Date | Opp | Res | MIN | FG | 3P | FT | PTS | REB | AST | RNP | TS% | PRF |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-12 | vs MIL | W | 27.0 | 8/13 | 2/5 | 3/3 | 21 | 2 | 1 | 4.1 | 73.3% | 24.0 |
| 2026-04-10 | @ IND | W | 38.5 | 11/28 | 1/10 | 9/10 | 32 | 8 | 5 | 13.1 | 49.4% | 45.0 |
| 2026-04-09 | @ HOU | L | 33.3 | 9/20 | 5/10 | 1/1 | 24 | 3 | 5 | 4.8 | 58.7% | 37.0 |
| 2026-04-06 | @ SAS | L | 39.6 | 6/16 | 1/4 | 2/2 | 15 | 3 | 8 | -6.0 | 44.4% | 35.0 |
| 2026-04-04 | vs DET | L | 33.2 | 8/17 | 2/5 | 5/7 | 23 | 1 | 1 | -1.0 | 57.3% | 26.0 |
| 2026-04-03 | vs MIN | W | 34.9 | 7/13 | 1/3 | 6/6 | 21 | 6 | 8 | 3.0 | 67.1% | 39.0 |
| 2026-04-01 | @ WAS | W | 34.0 | 12/20 | 1/5 | 3/4 | 28 | 2 | 9 | 8.2 | 64.3% | 48.0 |
| 2026-03-30 | @ MIA | L | 43.9 | 7/20 | 2/9 | 7/7 | 23 | 7 | 9 | 1.5 | 49.8% | 46.0 |
| 2026-03-28 | @ CHA | W | 43.0 | 10/18 | 3/6 | 3/4 | 26 | 7 | 8 | 5.5 | 65.8% | 45.0 |
| 2026-03-07 | @ ATL | L | 37.9 | 12/22 | 3/7 | 4/4 | 31 | 2 | 5 | -0.5 | 65.2% | 44.0 |
| 2026-03-04 | vs UTA | W | 37.9 | 8/22 | 2/10 | 7/7 | 25 | 2 | 6 | 12.5 | 49.8% | 38.0 |
| 2026-03-03 | vs SAS | L | 25.1 | 8/19 | 2/6 | 3/4 | 21 | 8 | 2 | -2.0 | 50.6% | 26.0 |
| 2026-03-01 | @ BOS | L | 43.3 | 12/34 | 4/11 | 5/6 | 33 | 3 | 6 | 5.7 | 45.0% | 48.0 |
| 2026-02-26 | vs MIA | W | 37.8 | 9/26 | 5/12 | 5/5 | 28 | 4 | 11 | 7.8 | 49.6% | 56.0 |
| 2026-02-24 | @ IND | W | 33.6 | 10/22 | 2/8 | 10/10 | 32 | 9 | 8 | 17.1 | 60.6% | 49.0 |
| 2026-02-22 | @ MIN | W | 35.5 | 16/28 | 4/7 | 3/5 | 39 | 3 | 8 | 18.1 | 64.6% | 60.0 |
| 2026-02-21 | @ NOP | L | 36.2 | 9/23 | 2/11 | 7/8 | 27 | 3 | 7 | 4.7 | 50.9% | 45.0 |
| 2026-02-19 | vs ATL | L | 38.8 | 8/23 | 4/11 | 8/8 | 28 | 3 | 3 | 0.3 | 52.8% | 34.0 |
| 2026-02-11 | vs NYK | L | 32.1 | 9/21 | 3/8 | 11/13 | 32 | 2 | 2 | 10.5 | 59.9% | 36.0 |
| 2026-02-09 | @ POR | L | 32.5 | 10/21 | 2/9 | 8/8 | 30 | 1 | 4 | 4.8 | 61.2% | 41.0 |
| 2026-02-07 | @ PHX | W | 39.8 | 8/21 | 3/10 | 10/11 | 29 | 9 | 6 | 12.8 | 56.1% | 41.0 |
| 2026-02-05 | @ LAL | L | 37.4 | 11/22 | 1/9 | 3/4 | 26 | 0 | 13 | 13.8 | 54.7% | 53.0 |
| 2026-02-03 | @ GSW | W | 33.7 | 3/9 | 1/5 | 7/7 | 14 | 4 | 3 | -2.1 | 57.9% | 22.0 |
| 2026-02-02 | @ LAC | W | 35.9 | 9/18 | 7/14 | 4/4 | 29 | 5 | 6 | 11.9 | 73.4% | 43.0 |
| 2026-01-31 | vs NOP | W | 35.3 | 7/18 | 4/9 | 0/0 | 18 | 5 | 8 | -3.1 | 50.0% | 37.0 |
| 2026-01-29 | vs SAC | W | 40.6 | 12/18 | 4/9 | 12/13 | 40 | 4 | 8 | 17.0 | 84.3% | 58.0 |
| 2026-01-27 | vs MIL | W | 36.0 | 9/19 | 2/8 | 2/2 | 22 | 3 | 9 | 1.8 | 55.3% | 47.0 |
| 2026-01-26 | @ CHA | L | 25.3 | 3/12 | 0/3 | 0/0 | 6 | 2 | 7 | -9.2 | 25.0% | 22.0 |
| 2026-01-24 | vs NYK | L | 38.1 | 8/15 | 3/7 | 3/3 | 22 | 3 | 6 | -3.9 | 67.4% | 36.0 |
| 2026-01-22 | vs HOU | W | 42.7 | 15/28 | 2/10 | 4/4 | 36 | 2 | 10 | 0.0 | 60.5% | 59.0 |
| 2026-01-20 | vs PHX | L | 42.7 | 7/25 | 2/8 | 4/5 | 20 | 2 | 7 | -1.4 | 36.8% | 38.0 |
| 2026-01-19 | vs IND | W | 40.2 | 12/24 | 1/4 | 4/4 | 29 | 4 | 8 | 7.9 | 56.3% | 47.0 |
| 2026-01-16 | vs CLE | L | 38.7 | 9/23 | 2/8 | 2/2 | 22 | 5 | 9 | 0.2 | 46.1% | 44.0 |
| 2026-01-14 | vs CLE | L | 31.2 | 5/16 | 2/8 | 2/2 | 14 | 2 | 4 | -8.7 | 41.5% | 24.0 |
| 2026-01-12 | @ TOR | W | 34.9 | 10/16 | 6/9 | 7/7 | 33 | 4 | 2 | 11.6 | 86.5% | 37.0 |
| 2026-01-11 | @ TOR | L | 44.5 | 13/27 | 2/7 | 10/12 | 38 | 4 | 5 | 14.0 | 58.9% | 50.0 |
| 2026-01-09 | @ ORL | W | 37.9 | 10/22 | 3/8 | 6/6 | 29 | 1 | 1 | 3.9 | 58.8% | 31.0 |
| 2026-01-07 | vs WAS | W | 28.4 | 9/15 | 4/10 | 0/1 | 22 | 3 | 8 | 5.2 | 71.2% | 40.0 |
| 2026-01-05 | vs DEN | L | 45.6 | 10/22 | 4/9 | 4/6 | 28 | 6 | 6 | 6.5 | 56.8% | 41.0 |
| 2026-01-03 | @ NYK | W | 37.4 | 14/22 | 6/9 | 2/4 | 36 | 8 | 4 | 4.3 | 75.8% | 46.0 |
| 2026-01-01 | @ DAL | W | 42.4 | 14/24 | 4/10 | 2/2 | 34 | 8 | 10 | 18.2 | 68.3% | 57.0 |
| 2025-12-30 | @ MEM | W | 43.1 | 13/21 | 4/7 | 4/5 | 34 | 4 | 12 | 3.3 | 73.3% | 62.0 |
| 2025-12-28 | @ OKC | L | 36.4 | 10/18 | 2/7 | 6/7 | 28 | 2 | 5 | 6.7 | 66.4% | 41.0 |
| 2025-12-26 | @ CHI | L | 40.4 | 9/24 | 5/11 | 4/4 | 27 | 5 | 8 | -0.2 | 52.4% | 45.0 |
| 2025-12-23 | vs BKN | L | 39.3 | 3/14 | 0/5 | 7/7 | 13 | 3 | 2 | -1.5 | 38.1% | 18.0 |
| 2025-12-20 | vs DAL | W | 40.7 | 15/31 | 5/11 | 3/3 | 38 | 2 | 4 | 8.9 | 58.8% | 47.0 |
| 2025-12-19 | @ NYK | W | 37.8 | 11/24 | 6/12 | 2/2 | 30 | 2 | 9 | 12.5 | 60.3% | 52.0 |
| 2025-12-07 | vs LAL | L | 38.8 | 11/24 | 5/8 | 1/2 | 28 | 7 | 9 | 2.2 | 56.3% | 51.0 |
| 2025-12-05 | @ MIL | W | 36.8 | 5/14 | 0/3 | 2/2 | 12 | 4 | 4 | 3.8 | 40.3% | 23.0 |
| 2025-12-04 | vs GSW | W | 39.7 | 13/27 | 4/10 | 5/5 | 35 | 3 | 2 | 8.5 | 59.9% | 40.0 |
| 2025-12-02 | vs WAS | W | 28.8 | 13/26 | 4/9 | 5/5 | 35 | 4 | 6 | 19.6 | 62.1% | 51.0 |
| 2025-11-30 | vs ATL | L | 52.3 | 14/31 | 2/13 | 14/17 | 44 | 7 | 9 | 17.3 | 57.2% | 67.0 |
| 2025-11-28 | @ BKN | W | 41.8 | 7/16 | 2/8 | 6/6 | 22 | 9 | 7 | 6.7 | 59.0% | 37.0 |
| 2025-11-25 | vs ORL | L | 32.0 | 7/15 | 1/5 | 5/6 | 20 | 1 | 4 | 1.2 | 56.7% | 29.0 |
| 2025-11-23 | vs MIA | L | 36.3 | 10/23 | 5/14 | 2/2 | 27 | 3 | 6 | -1.4 | 56.5% | 42.0 |
| 2025-11-20 | @ MIL | W | 46.6 | 18/30 | 6/15 | 12/14 | 54 | 5 | 9 | 22.4 | 74.7% | 78.0 |
| 2025-11-19 | vs TOR | L | 38.5 | 8/14 | 5/9 | 3/4 | 24 | 2 | 9 | 4.5 | 76.1% | 46.0 |
| 2025-11-17 | vs LAC | W | 41.0 | 13/27 | 4/11 | 9/10 | 39 | 3 | 6 | 12.1 | 62.1% | 53.0 |
| 2025-11-14 | @ DET | L | 39.6 | 13/31 | 2/11 | 3/3 | 31 | 7 | 3 | 7.6 | 48.0% | 39.0 |
| 2025-11-11 | vs BOS | W | 33.6 | 5/17 | 3/6 | 8/8 | 21 | 5 | 9 | 6.1 | 51.2% | 43.0 |
| 2025-11-09 | vs DET | L | 38.1 | 10/26 | 4/12 | 9/9 | 33 | 4 | 7 | 12.6 | 55.1% | 50.0 |
| 2025-11-08 | vs TOR | W | 42.6 | 12/24 | 3/10 | 4/5 | 31 | 4 | 7 | 9.6 | 59.2% | 45.0 |
| 2025-11-05 | @ CLE | L | 36.5 | 10/20 | 2/5 | 5/8 | 27 | 7 | 9 | 6.2 | 57.4% | 49.0 |
| 2025-11-04 | @ CHI | L | 39.3 | 14/26 | 6/10 | 5/5 | 39 | 5 | 5 | 12.1 | 69.1% | 51.0 |
| 2025-11-02 | @ BKN | W | 38.8 | 9/19 | 4/9 | 4/4 | 26 | 6 | 7 | 6.6 | 62.6% | 42.0 |
| 2025-10-31 | vs BOS | L | 43.6 | 8/16 | 4/9 | 6/7 | 26 | 8 | 14 | 16.8 | 68.1% | 57.0 |
| 2025-10-28 | @ WAS | W | 47.4 | 11/25 | 3/9 | 14/16 | 39 | 3 | 10 | 13.4 | 60.9% | 65.0 |
| 2025-10-27 | vs ORL | W | 41.5 | 15/32 | 4/11 | 9/10 | 43 | 4 | 8 | 14.4 | 59.1% | 62.0 |
| 2025-10-25 | vs CHA | W | 41.8 | 7/20 | 4/9 | 10/12 | 28 | 6 | 9 | 6.0 | 55.4% | 53.0 |
| 2025-10-22 | @ BOS | W | 41.4 | 13/24 | 7/9 | 7/8 | 40 | 2 | 6 | 13.0 | 72.7% | 56.0 |